EH
IHE icon

Equitable Holdings’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Equitable Holdings’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$244K Hold
2,877
– – ﹤0.01% 1543
2025
Q4 		$244K Hold
2,877
– – ﹤0.01% 1420
2025
Q3 		$209K Buy
+2,877
New +$198K ﹤0.01% 1437
2025
Q2 		– Sell
-3,028
Closed -$214K – 1478
2025
Q1 		$214K Sell
3,028
-1,037
-26% -$72.1K ﹤0.01% 1227
2024
Q4 		$267K Buy
4,065
+811
+25% +$55.8K ﹤0.01% 1090
2024
Q3 		$230K Buy
+3,254
New +$227K ﹤0.01% 1139

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Equitable Holdings's IHE Position: Q1 2026 in Review

Equitable Holdings held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 2,877 shares worth $244K. The position accounts for ﹤0.01% of the portfolio, ranked #1543.

Equitable Holdings first reported a position in IHE in Q3 2024 and has held it in 6 quarters since. The position peaked at $267K in Q4 2024. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Equitable Holdings held 2,877 shares of iShares US Pharmaceuticals ETF worth $244K as of Q1 2026.
  • Equitable Holdings left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Equitable Holdings's portfolio in Q1 2026, its #1543 holding.
  • Equitable Holdings first reported a position in iShares US Pharmaceuticals ETF in Q3 2024 and has held it in 6 quarters since.
  • Equitable Holdings's iShares US Pharmaceuticals ETF position peaked at $267K in Q4 2024.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.